APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Tumor Embolization

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lung Tumor Embolization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026183 pages

Choose your research edition.

Industry ResearchLung Tumor Embolization Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Tumor Embolization Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Lung Tumor Embolization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Tumor Embolization Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Tumor Embolization Market Analysis and Forecast 2026-2032175 pages · $4,950 USD

Market perspective

The global Lung Tumor Embolization market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lung Tumor Embolization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung Tumor Embolization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Tumor Embolization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lung Tumor Embolization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lung Tumor Embolization include Tendfo, Medtronic, Olympus, Penumbra and Inari Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lung Tumor Embolization market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung Tumor Embolization and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung Tumor Embolization revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lung Tumor Embolization market size, projected growth trends, production technologies, key applications, and end-use industries.

Lung Tumor Embolization Segment by Company

Tendfo

Medtronic

Olympus

Penumbra

Inari Medical

Lung Tumor Embolization Segment by Type

Transarterial chemoembolization (TACE)

Transarterial Radioembolization (TARE)

Others

Lung Tumor Embolization Segment by Application

Hospitals

Ambulatory Surgical Centers

Lung Tumor Embolization Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Tumor Embolization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Tumor Embolization and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Tumor Embolization.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lung Tumor Embolization in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung Tumor Embolization industry.

Chapter 3: Detailed analysis of Lung Tumor Embolization companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Tumor Embolizationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung Tumor Embolization Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Transarterial chemoembolization (TACE) Table 3. Key Players of Transarterial Radioembolization (TARE) Table 4. Key Players of Others Table 4. Global Lung Tumor Embolization Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals Table 6. Key Players of Ambulatory Surgical Centers Table 7. Global Lung Tumor Embolization Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Lung Tumor Embolization Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Lung Tumor Embolization Market Share by Region (2021-2026) Table 10. Global Lung Tumor Embolization Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Lung Tumor Embolization Market Share by Region (2027-2032) Table 12. Lung Tumor Embolization Industry Trends Table 13. Lung Tumor Embolization Industry Drivers Table 14. Lung Tumor Embolization Industry Opportunities and Challenges Table 15. Lung Tumor Embolization Industry Restraints Table 16. Global Lung Tumor Embolization Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Lung Tumor Embolization Revenue Market Share by Company (2021-2026) Table 18. Global Lung Tumor Embolization Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lung Tumor Embolization Key Company Head Office and Area Served Table 20. Global Lung Tumor Embolization Company, Product Type & Application Table 21. Global Lung Tumor Embolization Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Lung Tumor Embolization by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Lung Tumor Embolization Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Lung Tumor Embolization Revenue Market Share by Type (2021-2026) Table 28. Global Lung Tumor Embolization Revenue Market Share by Type (2027-2032) Table 29. Global Lung Tumor Embolization Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Lung Tumor Embolization Revenue Market Share by Application (2021-2026) Table 33. Global Lung Tumor Embolization Revenue Market Share by Application (2027-2032) Table 34. Tendfo Company Information Table 35. Tendfo Business Overview Table 36. Tendfo Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Tendfo Lung Tumor Embolization Product Portfolio Table 38. Tendfo Recent Development Table 39. Medtronic Company Information Table 40. Medtronic Business Overview Table 41. Medtronic Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Medtronic Lung Tumor Embolization Product Portfolio Table 43. Medtronic Recent Development Table 44. Olympus Company Information Table 45. Olympus Business Overview Table 46. Olympus Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Olympus Lung Tumor Embolization Product Portfolio Table 48. Olympus Recent Development Table 49. Penumbra Company Information Table 50. Penumbra Business Overview Table 51. Penumbra Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Penumbra Lung Tumor Embolization Product Portfolio Table 53. Penumbra Recent Development Table 54. Inari Medical Company Information Table 55. Inari Medical Business Overview Table 56. Inari Medical Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Inari Medical Lung Tumor Embolization Product Portfolio Table 58. Inari Medical Recent Development Table 59. North America Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 60. North America Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 61. North America Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 62. North America Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 63. North America Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Lung Tumor Embolization Market Size by Country (2021-2026) Table 65. North America Lung Tumor Embolization Market Size by Country (2027-2032) Table 66. Europe Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 67. Europe Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 68. Europe Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 69. Europe Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 70. Europe Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Lung Tumor Embolization Market Size by Country (2021-2026) Table 72. Europe Lung Tumor Embolization Market Size by Country (2027-2032) Table 73. China Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 74. China Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 75. China Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 76. China Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 78. Asia Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 79. Asia Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 80. Asia Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 81. Asia Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Lung Tumor Embolization Market Size by Country (2021-2026) Table 83. Asia Lung Tumor Embolization Market Size by Country (2027-2032) Table 84. South America, Middle East & Africa Lung Tumor Embolization Market Size by Type (2021-2026) & (US$ Million) Table 85. South America, Middle East & Africa Lung Tumor Embolization Market Size by Type (2027-2032) & (US$ Million) Table 86. South America, Middle East & Africa Lung Tumor Embolization Market Size by Application (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Lung Tumor Embolization Market Size by Application (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2021-2026) Table 90. South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Lung Tumor Embolization Product Image Figure 2. Global Lung Tumor Embolization Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lung Tumor Embolization Market Share by Type: 2025 VS 2032 Figure 4. Transarterial chemoembolization (TACE) Image Figure 5. Transarterial Radioembolization (TARE) Image Figure 6. Others Image Figure 7. Global Lung Tumor Embolization Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Lung Tumor Embolization Market Share by Application: 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Ambulatory Surgical Centers Image Figure 11. Global Lung Tumor Embolization Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 13. Global Lung Tumor Embolization Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Lung Tumor Embolization Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Lung Tumor Embolization Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lung Tumor Embolization Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lung Tumor Embolization Revenue Market Share by Type (2021-2032) Figure 20. Global Lung Tumor Embolization Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lung Tumor Embolization Revenue Market Share by Application (2021-2032) Figure 22. North America Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 23. North America Lung Tumor Embolization Market Share by Type (2021-2032) Figure 24. North America Lung Tumor Embolization Market Share by Application (2021-2032) Figure 25. North America Lung Tumor Embolization Market Share by Country (2021-2032) Figure 26. United States Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 27. Canada Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 29. Europe Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 30. Europe Lung Tumor Embolization Market Share by Type (2021-2032) Figure 31. Europe Lung Tumor Embolization Market Share by Application (2021-2032) Figure 32. Europe Lung Tumor Embolization Market Share by Country (2021-2032) Figure 33. Germany Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 34. France Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 36. Italy Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 37. Russia Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 39. China Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 40. China Lung Tumor Embolization Market Share by Type (2021-2032) Figure 41. China Lung Tumor Embolization Market Share by Application (2021-2032) Figure 42. Asia Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 43. Asia Lung Tumor Embolization Market Share by Type (2021-2032) Figure 44. Asia Lung Tumor Embolization Market Share by Application (2021-2032) Figure 45. Asia Lung Tumor Embolization Market Share by Country (2021-2032) Figure 46. Japan Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 50. India Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 51. Australia Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Lung Tumor Embolization Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Lung Tumor Embolization Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Lung Tumor Embolization Market Share by Country (2021-2032) Figure 56. Brazil Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 61. UAE Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 63. Chile Lung Tumor Embolization Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Transarterial chemoembolization (TACE)
  • Transarterial Radioembolization (TARE)
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Tendfo
  • Medtronic
  • Olympus
  • Penumbra
  • Inari Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lung Tumor Embolization Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Transarterial chemoembolization (TACE)
  5. 1.2.3 Transarterial Radioembolization (TARE)
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Lung Tumor Embolization Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Ambulatory Surgical Centers
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Lung Tumor Embolization Growth Trends by Region
  13. 1.5.1 Global Lung Tumor Embolization Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Lung Tumor Embolization Market Size by Region (2021-2026)
  15. 1.5.3 Lung Tumor Embolization Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Lung Tumor Embolization Market Dynamics
  1. 2.1 Lung Tumor Embolization Industry Trends
  2. 2.2 Lung Tumor Embolization Industry Drivers
  3. 2.3 Lung Tumor Embolization Industry Opportunities and Challenges
  4. 2.4 Lung Tumor Embolization Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lung Tumor Embolization Revenue by Company (2021-2026)
  2. 3.2 Global Lung Tumor Embolization Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lung Tumor Embolization Key Company Head office and Area Served
  4. 3.4 Global Lung Tumor Embolization Company, Product Type & Application
  5. 3.5 Global Lung Tumor Embolization Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lung Tumor Embolization Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lung Tumor Embolization Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lung Tumor Embolization Tier 1, Tier 2, and Tier 3
4 Lung Tumor Embolization Market by Type
  1. 4.1 Global Lung Tumor Embolization Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lung Tumor Embolization Market Size by Type (2021-2032)
  3. 4.3 Global Lung Tumor Embolization Market Size Share by Type (2021-2032)
5 Lung Tumor Embolization Market by Application
  1. 5.1 Global Lung Tumor Embolization Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lung Tumor Embolization Market Size by Application (2021-2032)
  3. 5.3 Global Lung Tumor Embolization Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Tendfo
  2. 6.1.1 Tendfo Company Information
  3. 6.1.2 Tendfo Business Overview
  4. 6.1.3 Tendfo Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Tendfo Lung Tumor Embolization Product Portfolio
  6. 6.1.5 Tendfo Recent Developments
  7. 6.2 Medtronic
  8. 6.2.1 Medtronic Company Information
  9. 6.2.2 Medtronic Business Overview
  10. 6.2.3 Medtronic Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Medtronic Lung Tumor Embolization Product Portfolio
  12. 6.2.5 Medtronic Recent Developments
  13. 6.3 Olympus
  14. 6.3.1 Olympus Company Information
  15. 6.3.2 Olympus Business Overview
  16. 6.3.3 Olympus Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Olympus Lung Tumor Embolization Product Portfolio
  18. 6.3.5 Olympus Recent Developments
  19. 6.4 Penumbra
  20. 6.4.1 Penumbra Company Information
  21. 6.4.2 Penumbra Business Overview
  22. 6.4.3 Penumbra Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Penumbra Lung Tumor Embolization Product Portfolio
  24. 6.4.5 Penumbra Recent Developments
  25. 6.5 Inari Medical
  26. 6.5.1 Inari Medical Company Information
  27. 6.5.2 Inari Medical Business Overview
  28. 6.5.3 Inari Medical Lung Tumor Embolization Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Inari Medical Lung Tumor Embolization Product Portfolio
  30. 6.5.5 Inari Medical Recent Developments
7 North America
  1. 7.1 North America Lung Tumor Embolization Market Size (2021-2032)
  2. 7.2 North America Lung Tumor Embolization Market Size by Type
  3. 7.2.1 North America Lung Tumor Embolization Market Size by Type (2021-2026)
  4. 7.2.2 North America Lung Tumor Embolization Market Size by Type (2027-2032)
  5. 7.2.3 North America Lung Tumor Embolization Market Share by Type (2021-2032)
  6. 7.3 North America Lung Tumor Embolization Market Size by Application
  7. 7.3.1 North America Lung Tumor Embolization Market Size by Application (2021-2026)
  8. 7.3.2 North America Lung Tumor Embolization Market Size by Application (2027-2032)
  9. 7.3.3 North America Lung Tumor Embolization Market Share by Application (2021-2032)
  10. 7.4 North America Lung Tumor Embolization Market Size by Country
  11. 7.4.1 North America Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lung Tumor Embolization Market Size by Country (2021-2026)
  13. 7.4.3 North America Lung Tumor Embolization Market Size by Country (2027-2032)
  14. 7.4.4 North America Lung Tumor Embolization Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lung Tumor Embolization Market Size (2021-2032)
  2. 8.2 Europe Lung Tumor Embolization Market Size by Type
  3. 8.2.1 Europe Lung Tumor Embolization Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lung Tumor Embolization Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lung Tumor Embolization Market Share by Type (2021-2032)
  6. 8.3 Europe Lung Tumor Embolization Market Size by Application
  7. 8.3.1 Europe Lung Tumor Embolization Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lung Tumor Embolization Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lung Tumor Embolization Market Share by Application (2021-2032)
  10. 8.4 Europe Lung Tumor Embolization Market Size by Country
  11. 8.4.1 Europe Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lung Tumor Embolization Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lung Tumor Embolization Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lung Tumor Embolization Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lung Tumor Embolization Market Size (2021-2032)
  2. 9.2 China Lung Tumor Embolization Market Size by Type
  3. 9.2.1 China Lung Tumor Embolization Market Size by Type (2021-2026)
  4. 9.2.2 China Lung Tumor Embolization Market Size by Type (2027-2032)
  5. 9.2.3 China Lung Tumor Embolization Market Share by Type (2021-2032)
  6. 9.3 China Lung Tumor Embolization Market Size by Application
  7. 9.3.1 China Lung Tumor Embolization Market Size by Application (2021-2026)
  8. 9.3.2 China Lung Tumor Embolization Market Size by Application (2027-2032)
  9. 9.3.3 China Lung Tumor Embolization Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lung Tumor Embolization Market Size (2021-2032)
  2. 10.2 Asia Lung Tumor Embolization Market Size by Type
  3. 10.2.1 Asia Lung Tumor Embolization Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lung Tumor Embolization Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lung Tumor Embolization Market Share by Type (2021-2032)
  6. 10.3 Asia Lung Tumor Embolization Market Size by Application
  7. 10.3.1 Asia Lung Tumor Embolization Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lung Tumor Embolization Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lung Tumor Embolization Market Share by Application (2021-2032)
  10. 10.4 Asia Lung Tumor Embolization Market Size by Country
  11. 10.4.1 Asia Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lung Tumor Embolization Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lung Tumor Embolization Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lung Tumor Embolization Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lung Tumor Embolization Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lung Tumor Embolization Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lung Tumor Embolization Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lung Tumor Embolization Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lung Tumor Embolization Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lung Tumor Embolization Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lung Tumor Embolization Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lung Tumor Embolization Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lung Tumor Embolization Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lung Tumor Embolization Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lung Tumor Embolization Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lung Tumor Embolization Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst